Logo
Logo

About Cetirizine Dihydrochloride API

Product
  • Therapeutic CategoryRespiratory

  • CAS Number

    83881-52-1

  • API Technology

    Synthetic

  • Dose Form

    Oral Solids, Liquid, Opthalmic

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted, Brazil DMF, Korea DMF, Russia DMF

Mechanism of Action

Cetirizine, a metabolite of hydroxyzine, is an antihistamine; its principal effects are mediated via selective inhibition of H1 receptors.

Indication

Indicated for the relief of nasal and non-nasal symptoms associated with seasonal or perennial allergic rhinitis in adults and children 12 years of age and older.

Related APIs

Cetirizine Dihydrochloride

Respiratory

arrow

Desloratadine

Respiratory

arrow

Fexofenadine Hydrochloride (Form 1)

Respiratory

arrow

Levocetirizine Dihydrochloride

Respiratory

arrow

Montelukast Sodium

Respiratory

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.